Revival of an old stressor: Dobutamine-stimulation for PET myocardial perfusion imaging in patients with end-stage liver disease?

J Nucl Cardiol. 2020 Dec;27(6):2060-2062. doi: 10.1007/s12350-018-01543-5. Epub 2018 Dec 4.

Authors

Thomas H Schindler¹, Thorsten Leucker²

Affiliations

¹ Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway, St. Louis, MO, 63110, USA. [email protected].
² Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

PMID: 30515744
DOI: 10.1007/s12350-018-01543-5

No abstract available

Publication types

Editorial
Comment

MeSH terms

Dobutamine
End Stage Liver Disease*
Humans
Myocardial Perfusion Imaging*
Positron Emission Tomography Computed Tomography
Rubidium Radioisotopes
Tomography, X-Ray Computed
Vasodilation

Substances

Rubidium Radioisotopes
Dobutamine
Rubidium-82